Goodwin has emerged as the leading global advisor for all private equity stages in the first quarter of 2026, according to the latest data from LSEG. The firm secured the top spot by deal count in the LSEG Global Venture Capital and Private Equity Legal Advisory League Tables, signaling a period of significant momentum across the private markets landscape.
The LSEG rankings are complemented by data from PitchBook, which named Goodwin the top firm for venture capital exits during the same period. This dual recognition across two of the industry’s most cited data providers suggests a broad capacity to handle deals from early-stage funding through to the final realization of value.
For those tracking the flow of global capital, these results highlight a shift toward legal advisors who can operate as business strategists. Goodwin’s performance is particularly pronounced in the “Advisor to Firm” category, where it led the market in all private equity stages, reflecting a deep trust from the funds and institutional investors driving the current deal cycle.
Breaking down the Q1 2026 benchmarks
The LSEG data provides a granular look at where Goodwin is capturing the most volume. While the firm took the overall lead for all private equity stages, it also maintained high rankings in more specialized categories, including venture capital rounds and leveraged buyouts (LBOs).
The distinction between “Advisor to Firm” and “Advisor to Company” is critical in these league tables. Advising the firm typically involves representing the private equity or venture capital fund, whereas advising the company involves representing the target or the portfolio entity. Goodwin’s #1 ranking as an advisor to firms indicates a strong grip on the buy-side of the market.
| LSEG Category (Q1 2026) | Global Rank (Deal Count) |
|---|---|
| Advisor to Firm – All PE Stages | #1 |
| Advisor to Firm – VC Rounds | #2 |
| Advisor to Company – All PE Stages | #3 |
| Advisor to Company – VC Rounds | #3 |
| Advisor to Company – LBO & Related | #3 |
This breadth across the Goodwin private equity league tables Q1 2026 results suggests the firm is not relying on a single “mega-deal” to inflate its numbers, but is instead processing a high volume of transactions across various deal sizes and structures.
The significance of venture capital exits
While deal volume is a measure of activity, the PitchBook Global League Tables highlight a different, often more critical metric: the exit. PitchBook ranked Goodwin as the number one firm for venture capital exits in Q1 2026.
In the venture capital ecosystem, the exit—whether via an initial public offering (IPO) or a strategic acquisition—is the moment of truth where investors realize their returns. Leading in this category suggests that Goodwin is effectively guiding its clients through the most complex phase of the investment lifecycle, navigating the regulatory and financial hurdles required to close a deal.
Beyond exits, the PitchBook data shows a pervasive presence in specific sectors. The firm ranked #2 in private equity for IT and venture capital for both pharma and biotech, as well as transportation. This sector-specific strength is likely a result of the firm’s immersion in life sciences and technology, where legal requirements are often intertwined with complex intellectual property and regulatory frameworks.
Sector-driven legal strategy
The firm’s ability to scale across different industries is not accidental. The Q1 results reflect a strategy of “industry immersion,” where legal expertise is paired with deep knowledge of the underlying business. This represents particularly evident in the healthcare and technology sectors, where the firm holds multiple top-five positions.
According to the data, Goodwin’s reach extends into several niche areas of venture capital, including consumer goods and services, early-stage and late-stage VC, and IT hardware. By maintaining high rankings in both early-stage and late-stage deals, the firm is positioned to support a company from its seed round all the way to its eventual exit.
This comprehensive approach is further reflected in the broader M&A and private equity rankings. In the United States, the firm placed #4 for M&A and #4 for private equity, while maintaining a top-five global position for M&A and European deal combinations.
The integration of business advisory expertise with legal excellence allows firms to move faster in volatile markets. When a legal team understands the operational nuances of a biotech firm or a software-as-a-service (SaaS) provider, the friction in drafting term sheets and conducting due diligence is significantly reduced.
Disclaimer: This article is for informational purposes only and does not constitute legal or financial advice.
As the market moves into the second quarter of 2026, the industry will be watching to see if this volume of activity persists amid shifting interest rates and regulatory scrutiny. The next major checkpoint for the industry will be the release of the Q2 league tables, which will indicate whether these early-year gains represent a long-term trend or a seasonal surge in deal-making.
We invite readers to share their thoughts on the current state of private equity and venture capital in the comments below.
